Viridans streptococci form a heterogeneous group of bacteria traditionally
associated with dental caries and recognised as the classical opportunistic
cause of infective endocarditis. More recently these organisms have emerge
d as significant pathogens in immunocompromised patients with malignant dis
ease. In addition to a marked increase in the number and severity of infect
ions caused by viridans streptococci over the last two decades, resistance
to antibiotics amongst these organisms has become widespread. Antimicrobial
therapy must be prescribed prudently to prevent selective pressure towards
overgrowth of resistant strains. Factors which may contribute to the devel
opment of infection by viridans streptococci include disease- or treatment-
associated immunocompromise, mucosal damage and antibiotic selection pressu
re. Further studies on potential virulence determinants are required to enh
ance our knowledge of the mechanisms involved in progression from colonisat
ion to infection. In the past, accurate and universally recognised phenotyp
ic identification schemes for viridans streptococci were elusive. With rece
nt advances in molecular characterisation of viridans streptococci, control
led prospective studies may determine whether particular species are associ
ated with specific patterns of infection or severity of disease. (C) 2000 L
ippincott Williams & Wilkins.